A New Continuing Education Course for Genetic Counseling in Parkinson Disease: James Beck, PhD
March 4th 2022The senior vice president and chief scientific officer of the Parkinson’s Foundation outlined the new CE course, as well as the benefits of being granted Joint Accreditation. [WATCH TIME: 4 mintues]
Necessary Steps to Combat Stigma in Epilepsy: Joan K. Austin, PhD, RN, FAAN
March 3rd 2022The Distinguished Professor Emerita at Indiana University School of Nursing outlined the next steps those in the field of epilepsy need to take to address and tackle this ongoing issue. [WATCH TIME: 3 minutes]
Tactics for Recognizing, Addressing Stigma in Epilepsy: Joan K. Austin, PhD, RN, FAAN
March 2nd 2022The Distinguished Professor Emerita at Indiana University School of Nursing spoke on key takeaways for clinicians when it comes to helping tackle stigma, as well as the need to educate patients and their families about the condition overall. [WATCH TIME: 4 minutes]
Treating Cognitive Deficits in MS With Transcranial Direct Current Stimulation: Leigh Charvet, PhD
March 2nd 2022The professor of neurology at the NYU Grossman School of Medicine discussed her presentation at ACTRIMS Forum 2022, which showed better cognitive outcomes in MS following treatment with tDCS. [WATCH TIME: 3 minutes]
Discussing Epstein-Barr Virus and Multiple Sclerosis: Bruce Bebo, PhD
March 1st 2022The executive vice president of the National MS Society spoke on recently published data suggesting the relationship between EBV and MS, also sharing his opinion on the potential of vaccines. [WATCH TIME: 2 minutes]
Ganaxolone’s Significant Effect on CDKL5 Deficiency Disorder: Elia Pestana-Knight, MD
March 1st 2022The pediatric epileptologist at Cleveland Clinic provided insight on her presentation at the 2022 AAN Annual Meeting that evaluated ganaxolone in phase 3 study of patients with CDKL5 deficiency disorder. [WATCH TIME: 4 minutes]
Raising Awareness for Rare Diseases, Myasthenia Gravis: Hong Sun, MD, PhD
February 28th 2022The global compound development team leader at Janssen discussed the importance of Rare Disease Day and one in particular, myasthenia gravis, which affects approximately 36,000 to 60,000 people in the US. [WATCH TIME: 3 minutes]
ACTRIMS Forum Takeaways and Unmet Needs in Multiple Sclerosis: Bruce Bebo, PhD
February 27th 2022The executive vice president of the National MS Society spoke on the primary theme of ‘biomarkers’ at this year’s meeting, as well as the areas he believes require the most attention for patients with MS. [WATCH TIME: 3 minutes]
Cost Efficiency and Promoting Healthy Lifestyles in Multiple Sclerosis: Bruce Bebo, PhD
February 25th 2022At the ACTRIMS Forum 2022, the executive vice president of the National MS Society commented on the need to diagnose and initiate treatment for MS early, as well as employing wellness strategies to reduce risk of comorbidities. [WATCH TIME: 4 minutes]
Discussing Economic Burden for Patients With Multiple Sclerosis: Bruce Bebo, PhD
February 24th 2022The executive vice president of the National MS Society spoke on the updated data from an analysis on economic burden, which illustrated the ‘staggering’ impact of the disease. [WATCH TIME: 4 minutes]
Gearing Up For the 2022 ACTRIMS Forum: Jeffrey Cohen, MD
February 24th 2022The professor of neurology at Cleveland Clinic and president of ACTRIMS noted his excitement for this year’s Forum, which will feature presentations on a variety of topics in the field of multiple sclerosis. [WATCH TIME: 2 minutes]
Discussing Findings From the ILAE Task Force on Stigma in Epilepsy: Joan K. Austin, PhD, RN, FAAN
February 23rd 2022The Distinguished Professor Emerita at Indiana University School of Nursing spoke on what the task force discovered in a review of literature on stigma from 1985 through 2019. [WATCH TIME: 7 minutes]
Raising Awareness of Neuropsychiatric Symptoms in Neurodegenerative Diseases: George Grossberg, MD
February 23rd 2022The director of Geriatric Psychiatry at the St Louis University School of Medicine discussed the need to improve awareness of the signs of psychiatric-related symptoms and to eliminate the stigmas associated with them. [WATCH TIME: 3 minutes]